XNAS: EXEL
Exelixis Inc Live Stock Price Today, Share Analysis and Chart
about
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...
Read More
52.99
1.25
(2.42%)
1.8M
XNAS Volume
XNAS 09 Jun, 2026 4:00 PM (EDT)
Board Meeting
The board meeting for Exelixis Inc is scheduled for today, for the purpose of Goldman Sachs 47th Annual Global Healthcare Conference
See details
Medium Financial Strength
Mid Valuation
Technically Moderately Bullish
Turnaround Potential
These stocks have average financials and valuation, but strong momentum indicating buying interest
View Similar
Embed DVM
Exelixis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..